Announced Mon, 29 Jun · 19:47 IST
HCG completes sale of BACC Health Care subsidiary to Inviga Healthcare Fund
Strategic Transactions View source PDF
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.8%1-day move
₹594.30
prior close
₹595.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+1.0+1.2+1.5+6.8+8.9+10.3+9.7+9.5+10.2+11.5———
Up moveDown movePending
AI summary
HCG has completed sale of its entire stake (99.999%, or 93,577 of 93,578 shares) in subsidiary BACC Health Care Private Limited to Inviga Healthcare Fund I on June 29, 2026. Total deal value is Rs 37.64 crores. Initial consideration of Rs 28.23 crores has been received. Balance of about Rs 9.41 crores is deferred and payable within 18 months of the May 19, 2026 signing, and is time-deferred only, not conditional.
Likely market impact
Brings in Rs 28.23 crores cash now and Rs 9.41 crores later. Exits the BACC subsidiary, removing its revenue, costs, and any related debt from HCG books.